31 related articles for article (PubMed ID: 38514918)
1. Association Between Rheumatoid Arthritis and the Risk of Lung Cancer.
Hsu CK; Lai CC
J Thorac Oncol; 2024 Jun; 19(6):e9. PubMed ID: 38849170
[No Abstract] [Full Text] [Related]
2. High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.
Tyker A; Ventura IB; Lee CT; Strykowski R; Garcia N; Guzy R; Jablonski R; Vij R; Strek ME; Chung JH; Adegunsoye A
Sci Rep; 2021 Nov; 11(1):22821. PubMed ID: 34819525
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis.
Yang JA; Lee JS; Park JK; Lee EB; Song YW; Lee EY
Korean J Intern Med; 2019 Mar; 34(2):434-441. PubMed ID: 28352064
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of U.S. Veterans.
Natalini JG; Baker JF; Singh N; Mahajan TD; Roul P; Thiele GM; Sauer BC; Johnson CR; Kawut SM; Mikuls TR; England BR
Ann Am Thorac Soc; 2021 Apr; 18(4):598-605. PubMed ID: 33026891
[No Abstract] [Full Text] [Related]
5. A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease.
Li L; Liu R; Zhang Y; Zhou J; Li Y; Xu Y; Gao S; Zheng Y
Clin Rheumatol; 2020 May; 39(5):1457-1470. PubMed ID: 31858341
[TBL] [Abstract][Full Text] [Related]
6. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.
Oka S; Higuchi T; Furukawa H; Shimada K; Okamoto A; Hashimoto A; Komiya A; Saisho K; Yoshikawa N; Katayama M; Matsui T; Fukui N; Migita K; Tohma S
BMC Musculoskelet Disord; 2022 Jan; 23(1):46. PubMed ID: 35027028
[TBL] [Abstract][Full Text] [Related]
7. Prognosis and prognostic factors of lung cancer complications in patients with rheumatoid arthritis.
Fujita S; Nakano K; Nagasu A; Hiramatsu-Asano S; Akagi T; Morita Y
Int J Rheum Dis; 2024 Mar; 27(3):e15069. PubMed ID: 38514918
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening?
Fragoulis GE; Chatzidionysiou K
Clin Rheumatol; 2020 Mar; 39(3):957-961. PubMed ID: 31836935
[TBL] [Abstract][Full Text] [Related]
9. Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management.
Dai Y; Wang W; Yu Y; Hu S
Clin Rheumatol; 2021 Apr; 40(4):1211-1220. PubMed ID: 32794076
[TBL] [Abstract][Full Text] [Related]
10. [Interstitial lung disease in rheumatoid arthritis].
Froidevaux-Janin S; Dudler J; Nicod LP; Lazor R
Rev Med Suisse; 2011 Nov; 7(318):2272-7. PubMed ID: 22400361
[TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis associated interstitial lung disease: a review.
Assayag D; Lee JS; King TE
Medicina (B Aires); 2014; 74(2):158-65. PubMed ID: 24736263
[TBL] [Abstract][Full Text] [Related]
12. Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease.
Kim Y; Yang HI; Kim KS
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833957
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
